<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.diabesityrounds.com/a/the-next-wave-of-glp-1-drugs-early-promise-but-cost-and-access-still-unclear</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-11T03:34:34.515Z</news:publication_date><news:title>The next wave of GLP-1 drugs: early promise, but cost and access still unclear</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/orforglipron-with-insulin-glargine-larger-hba1c-fall-than-placebo-in-phase-3</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-11T03:26:56.855Z</news:publication_date><news:title>Orforglipron with insulin glargine: larger HbA1c fall than placebo in phase 3</news:title></news:news></url></urlset>